title: Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
abstract: OBJECTIVE
  To compare assessment of regional cerebral metabolic changes with [(11)C]dihydrotetrabenazine (DTBZ)-positron emission tomography (PET) measurement of regional cerebral blood flow (K(1)) and fludeoxyglucose F18 (FDG)-PET measurement of regional cerebral glucose uptake (CMR(glc)) in a clinically representative sample of subjects with mild dementia and mild cognitive impairment (MCI).
  
  
  METHODS
  [(11)C]Dihydrotetrabenazine-PET K(1) and FDG-PET CMR(glc) measurements were performed.
  
  
  METHODS
  University-based cognitive disorders clinic.
  
  
  METHODS
  Fifty subjects with either mild dementia (Mini-Mental State Examination score > or = 18) or MCI. Their results were compared with those of 80 normal control subjects.
  
  
  METHODS
  The DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were compared with standard correlation analysis. The overall patterns of DTBZ-PET K(1) and FDG-PET CMR(glc) deficits were assessed with stereotaxic surface projections (SSPs) of parametric images.
  
  
  RESULTS
  The DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were highly correlated, both within and between subjects. The SSP maps of deficits in DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were markedly similar. The DTBZ-PET K(1) SSP maps exhibited a mild decrease in sensitivity relative to FDG-PET CMR(glc) maps.
  
  
  CONCLUSIONS
  Both DTBZ-PET K(1) and FDG-PET CMR(glc) measurements provide comparable information in assessment of regional cerebral metabolic deficits in mild dementia and MCI. Blood flow measures can assess regional cerebral metabolism deficits accurately in mild dementia and MCI. Blood flow assessments of regional cerebral metabolic deficits can be combined with tracer binding results to improve utility of PET imaging in mild dementia and MCI.
authors.affiliation: VA Ann Arbor Health System Geriatrics Research, Education, and Clinical Center, and Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, USA. ralbin@umich.edu
authors.forename: Roger L
authors.initials: RL
authors.lastname: Albin
authors.forename: Robert A
authors.initials: RA
authors.lastname: Koeppe
authors.forename: James F
authors.initials: JF
authors.lastname: Burke
authors.forename: Bruno
authors.initials: B
authors.lastname: Giordani
authors.forename: Michael R
authors.initials: MR
authors.lastname: Kilbourn
authors.forename: Sid
authors.initials: S
authors.lastname: Gilman
authors.forename: Kirk A
authors.initials: KA
authors.lastname: Frey
mesh_terms: D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D001667:Binding, Competitive / Q000502:physiology; D001931:Brain Mapping / Q000379:methods; D002250:Carbon Radioisotopes; D002540:Cerebral Cortex / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology; D003072:Cognition Disorders / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D003704:Dementia / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D042241:Early Diagnosis; D004734:Energy Metabolism / Q000502:physiology; D005260:Female; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D013747:Tetrabenazine / Q000031:analogs & derivatives*
chemical_list: D002250:Carbon Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C032811:dihydrotetrabenazine; D005947:Glucose; D013747:Tetrabenazine
references.citation: Neurology. 2002 Jun 11;58(11):1608-15
references.pmid: 12058087
references.citation: Ann Neurol. 2008 Oct;64(4):388-401
references.pmid: 18991338
references.citation: Brain. 2007 Oct;130(Pt 10):2616-35
references.pmid: 17704526
references.citation: Neuroimage. 2008 Jan 15;39(2):619-33
references.pmid: 17962045
references.citation: N Engl J Med. 1996 Mar 21;334(12):752-8
references.pmid: 8592548
references.citation: Neurology. 2007 Apr 10;68(15):1205-12
references.pmid: 17420404
references.citation: J Nucl Med. 2000 Nov;41(11):1920-8
references.pmid: 11079505
references.citation: Exp Neurol. 2000 Apr;162(2):247-56
references.pmid: 10739631
references.citation: Ann Neurol. 1997 Jul;42(1):85-94
references.pmid: 9225689
references.citation: Neurology. 2000 Mar 14;54(5):1050-8
references.pmid: 10720273
references.citation: J Nucl Med. 2005 Jun;46(6):936-44
references.pmid: 15937303
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):284-9
references.pmid: 14688411
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):100-6
references.pmid: 17846768
references.citation: Am J Psychiatry. 1985 May;142(5):638-40
references.pmid: 3872604
references.citation: J Nucl Med. 2008 Mar;49(3):390-8
references.pmid: 18287270
references.citation: J Intern Med. 2004 Sep;256(3):183-94
references.pmid: 15324362
references.citation: Ann Neurol. 2002 Jun;51(6):767-71
references.pmid: 12112084
references.citation: Br J Radiol. 2007 Dec;80 Spec No 2:S160-7
references.pmid: 18445746
references.citation: Neuroimage. 2002 Sep;17(1):302-16
references.pmid: 12482085
references.citation: Neurology. 2008 Sep 16;71(12):903-10
references.pmid: 18794492
references.citation: Ann Neurol. 2001 Sep;50(3):358-65
references.pmid: 11558792
references.citation: J Neurosci. 2005 Aug 24;25(34):7709-17
references.pmid: 16120771
references.citation: Neurology. 1996 Aug;47(2):462-6
references.pmid: 8757021
references.citation: Brain. 2007 Oct;130(Pt 10):2636-45
references.pmid: 17898010
references.citation: J Cereb Blood Flow Metab. 1983 Sep;3(3):391-4
references.pmid: 6603463
references.citation: Fed Proc. 1981 Jun;40(8):2311-6
references.pmid: 7238911
references.citation: Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):494-504
references.pmid: 10559566
references.citation: Brain. 1999 Aug;122 ( Pt 8):1449-68
references.pmid: 10430831
references.citation: Ann Neurol. 1984 Dec;16(6):649-54
references.pmid: 6335378
references.citation: Neurology. 1998 Dec;51(6):1546-54
references.pmid: 9855500
references.citation: Neurology. 2002 May 28;58(10):1489-93
references.pmid: 12034784
references.citation: J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):134-40
references.pmid: 12122169
references.citation: Neurology. 2003 Apr 22;60(8):1374-7
references.pmid: 12707450
references.citation: J Cereb Blood Flow Metab. 2006 Sep;26(9):1213-21
references.pmid: 16525414
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9
references.pmid: 11248079
references.citation: J Comput Assist Tomogr. 1995 Jul-Aug;19(4):541-7
references.pmid: 7622680
references.citation: J Nucl Med. 2002 Feb;43(2):253-66
references.pmid: 11850493
references.citation: J Nucl Med. 1995 Jul;36(7):1238-48
references.pmid: 7790950
references.citation: JAMA. 2001 Nov 7;286(17):2120-7
references.pmid: 11694153
references.citation: J Physiol. 1890 Jan;11(1-2):85-158.17
references.pmid: 16991945
references.citation: Neurology. 2001 May 8;56(9):1143-53
references.pmid: 11342678
references.citation: Neurology. 2007 Aug 28;69(9):871-7
references.pmid: 17724289
references.citation: J Cereb Blood Flow Metab. 1997 Sep;17(9):919-31
references.pmid: 9307605
references.citation: J Nucl Med. 1998 Nov;39(11):1875-8
references.pmid: 9829574
references.citation: Lancet. 1985 Jan 26;1(8422):228
references.pmid: 2857310
references.citation: Ann Neurol. 2003 Sep;54(3):343-51
references.pmid: 12953266
references.citation: Neuroimage. 2003 Sep;20(1):435-40
references.pmid: 14527604
references.citation: Neurology. 2005 Dec 27;65(12):1863-72
references.pmid: 16237129
references.citation: Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510
references.pmid: 15747152
references.citation: Neurology. 1984 Jul;34(7):939-44
references.pmid: 6610841
references.citation: Neurology. 2003 Oct 28;61(8):1138-40
references.pmid: 14581683
references.citation: Neuroreport. 2001 Mar 26;12(4):851-5
references.pmid: 11277595
references.citation: Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13
references.pmid: 12764551
references.citation: Neurology. 2007 May 15;68(20):1718-25
references.pmid: 17502554
references.citation: Neurobiol Aging. 2007 Jan;28(1):42-50
references.pmid: 16448722
references.citation: Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2169-81
references.pmid: 18566819
references.citation: Mol Neurobiol. 2008 Aug;38(1):1-15
references.pmid: 18690556
references.citation: Am J Psychiatry. 2002 May;159(5):738-45
references.pmid: 11986126
references.citation: J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):184-8
references.pmid: 10071097
references.citation: J Nucl Med. 1994 Sep;35(9):1528-37
references.pmid: 8071705
references.citation: Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):584-95
references.pmid: 15545326
references.citation: Annu Rev Neurosci. 2006;29:449-76
references.pmid: 16776593
references.citation: J Nucl Med. 2005 Feb;46(2):233-9
references.pmid: 15695781
references.citation: Ann Nucl Med. 2003 Apr;17(2):79-89
references.pmid: 12790355
references.citation: J Cereb Blood Flow Metab. 2005 Nov;25(11):1528-47
references.pmid: 15944649
references.citation: J Nucl Med. 2004 Apr;45(4):594-607
references.pmid: 15073255
references.citation: Proc Natl Acad Sci U S A. 2000 May 23;97(11):6037-42
references.pmid: 10811879
references.citation: Neurology. 2004 Jul 27;63(2):246-53
references.pmid: 15277616
references.citation: Ann Neurol. 2004 Jun;55(6):774-80
references.pmid: 15174011
references.citation: Neurology. 1999 Oct 12;53(6):1292-9
references.pmid: 10522887
references.citation: Lancet Neurol. 2007 Apr;6(4):305-13
references.pmid: 17362834
references.citation: Semin Nucl Med. 2008 Jul;38(4):251-61
references.pmid: 18514081
references.citation: Ann Neurol. 2004 Mar;55(3):306-19
references.pmid: 14991808